In the pathological condition of psoriasis, systemic IL‐17A elevation can trigger microglia activation, provoke pro‐inflammation mediators release, evoke neural inflammation effects, then inhibit hippocampal neurogenesis and result in depression development. Here, IL17A is linked to depressive disorder.